Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-31 @ 6:11 PM
Study NCT ID:
NCT06682793
Status:
RECRUITING
Last Update Posted:
2025-09-09
First Post:
2024-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Sponsor:
A2 Biotherapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2029-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-07
First Submit QC Date:
None
Study First Post Date:
2024-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-03
Last Update Post Date:
2025-09-09
Last Update Post Date Type:
ESTIMATED